To achieve its gene therapy goals, Precigen developed a proprietary electroporation device, UltraPorator, designed to ensure the rapid and cost-effective manufacturing of UltraCAR-T. The ...

(NASDAQ: VRTX) and CRISPR Therapeutics AG (NASDAQ: CRSP) to develop the world's first FDA-approved gene-editing treatment for ...

Delivering nucleic acids into cells is a critical step during cell therapy product development. Electroporation allows researchers to transfect a large number of cells in a short time. However, ...

Cell and gene therapy applications beyond cancer will continue to grow, likely with notable examples in autoimmune disease. Technologies like electroporation will continue to accelerate these ...

Gene, Cell & RNA Therapy Landscape Report. 3. Kitte R, Rabel M, Geczy R, Park S, Fricke S, Koehl U, Tretbar US. Lipid nanoparticles outperform electroporation in mRNA-based CAR T cell engineering.

The Gene Pulser Xcell System is a flexible, modular electroporation system for transfecting every cell type from primary, suspension, and difficult-to-transfect cells, including T cells, to bacteria ...

The facility is fully equipped for microinjections, microsurgery, zygote electroporation, gene targeting and tissue culture, and together with Purdue’s Gene Editing Facility and MilliporeSigma’s ...

Brief electroporation appears to make T cells more receptive to new genetic material ... A quick zap of electricity makes T cells more receptive to taking in new genetic material and gene-editing ...

In a report released today, Matt Hewitt from Craig-Hallum assigned a Buy rating to MaxCyte (MXCT – Research Report). The company’s shares ...